Literature DB >> 19034473

Clinical significance of eosinophilic cationic protein levels in nasal secretions of patients with nasal polyposis.

Dong-Il Sun1, Young-Hoon Joo, Hyeon-Jin Auo, Jun-Myung Kang.   

Abstract

Nasal polyps are characterized by eosinophilic infiltration, and frequently coexist with asthma, aspirin intolerance and allergy. Eosinophilic cationic protein (ECP) is a specific eosinophil granule protein released upon activation of eosinophils. We investigated the ECP levels in nasal secretions of patients with nasal polyposis (NP) in order to correlate them with disease severity and associated diseases and to compare ECP levels between patients with and without recurrence of NP after surgical treatment. A total of 78 patients who had surgery for NP were followed up for a minimum of 18 months. The presence of asthma, allergies or aspirin intolerance was noted. Nasal secretions were obtained 1 day before the surgery and during the follow-up period after surgery. Immunoassays were used to quantify ECP in nasal secretions and serum and interleukin (IL)-5 in nasal secretions. ECP levels in nasal secretions were higher in patients with asthma or aspirin intolerance than in patients without asthma or aspirin intolerance, while no significant differences were found between allergic and non-allergic patients. ECP levels in nasal secretions correlated significantly with IL-5 levels in nasal secretions, the degree of tissue eosinophilia and computed tomographic (CT) scores. In total, 30 patients (38%) developed recurrent NP during the follow-up period. Preoperative ECP and IL-5 levels in nasal secretions were significantly higher in patients with recurrence compared to patients without recurrence. During the follow-up period, patients without recurrence demonstrated a significant reduction in the ECP levels in nasal secretions, whereas there was no significant reduction in the ECP levels of patients with recurrence. The results of this study provide evidence that ECP levels in nasal secretions of patients with NP correlate with the presence of asthma or aspirin intolerance and severity of NP determined by CT scores.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19034473     DOI: 10.1007/s00405-008-0872-9

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  24 in total

1.  Outcome analysis of endoscopic sinus surgery for chronic sinusitis in patients having Samter's triad.

Authors:  Y G Amar; S Frenkiel; S E Sobol
Journal:  J Otolaryngol       Date:  2000-02

2.  EP3OS 2007: European position paper on rhinosinusitis and nasal polyps 2007. A summary for otorhinolaryngologists.

Authors:  Wytske Fokkens; Valerie Lund; Joaquim Mullol
Journal:  Rhinology       Date:  2007-06       Impact factor: 3.681

3.  Some risk factors for refractory chronic sinusitis: an immunohistochemical and electron microscopic study.

Authors:  Samy Elwany; Mohamed Bassyouni; Fikry Morad
Journal:  J Laryngol Otol       Date:  2002-02       Impact factor: 1.469

4.  Lung function and sputum characteristics of patients with severe asthma during an induced exacerbation by double-blind steroid withdrawal.

Authors:  J C in't Veen; H H Smits; P S Hiemstra; A E Zwinderman; P J Sterk; E H Bel
Journal:  Am J Respir Crit Care Med       Date:  1999-07       Impact factor: 21.405

5.  Expression of interleukins in patients with nasal polyposis.

Authors:  Richard Louis Voegels; Francini Grecco de Melo Pádua
Journal:  Otolaryngol Head Neck Surg       Date:  2005-04       Impact factor: 3.497

6.  Serum eosinophil cationic protein as a marker of eosinophilic inflammation in asthma.

Authors:  A Niimi; R Amitani; K Suzuki; E Tanaka; T Murayama; F Kuze
Journal:  Clin Exp Allergy       Date:  1998-02       Impact factor: 5.018

7.  Prognosis and prediction of response to surgery in allergic patients with chronic sinusitis.

Authors:  F Lavigne; C T Nguyen; L Cameron; Q Hamid; P M Renzi
Journal:  J Allergy Clin Immunol       Date:  2000-04       Impact factor: 10.793

8.  Specific immunoglobulin E for staphylococcal enterotoxins in nasal polyps from patients with aspirin-intolerant asthma.

Authors:  Y J Suh; S H Yoon; A P Sampson; H J Kim; S H Kim; D H Nahm; C H Suh; H S Park
Journal:  Clin Exp Allergy       Date:  2004-08       Impact factor: 5.018

9.  Eosinophil cationic protein in the nasal secretions of patients with mite allergic rhinitis.

Authors:  K Nishioka; C Saito; T Nagano; M Okano; Y Masuda; T Kuriyama
Journal:  Laryngoscope       Date:  1993-02       Impact factor: 3.325

10.  Eosinophil inflammation of the nasal mucosa in allergic and non-allergic rhinitis measured by eosinophil cationic protein levels in native nasal fluid and serum.

Authors:  G Rasp; P A Thomas; J Bujía
Journal:  Clin Exp Allergy       Date:  1994-12       Impact factor: 5.018

View more
  4 in total

1.  Letter to the editor concerning: 'Correlation between clinical findings and eosinophil/neutrophil ratio in patients with nasal polyps'.

Authors:  Satvinder Singh Bakshi
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-06-18       Impact factor: 2.503

2.  Intercellular adhesion molecule-1 expression in activated eosinophils is associated with mucosal remodeling in nasal polyps.

Authors:  Jingwei Xin; Hui Sun; Hong Kong; Lin Li; Jun Zheng; Chunxia Yin; Yang Cao; Yunxiao Jia; Chaoxu Li
Journal:  Mol Med Rep       Date:  2015-01-09       Impact factor: 2.952

3.  Hydrogen-rich saline attenuates eosinophil activation in a guinea pig model of allergic rhinitis via reducing oxidative stress.

Authors:  Shaoqing Yu; Chuanliang Zhao; Na Che; Lin Jing; Rongming Ge
Journal:  J Inflamm (Lond)       Date:  2017-01-13       Impact factor: 4.981

Review 4.  Cytokine Signature and Involvement in Chronic Rhinosinusitis with Nasal Polyps.

Authors:  Florent Carsuzaa; Émilie Béquignon; Xavier Dufour; Guillaume de Bonnecaze; Jean-Claude Lecron; Laure Favot
Journal:  Int J Mol Sci       Date:  2021-12-30       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.